Breakthrough trial tests first medicine targeting Autism's core challenges
NCT ID NCT06333964
Summary
This large, completed study tested whether a new medicine called AST-001 could improve the core social and behavioral challenges of autism in children. It involved 169 children in Korea and compared the medicine to a placebo. The goal was to see if this treatment could help where no other approved medicines currently exist for autism's main symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
-
Chungnam National University Hospital
Daejeon, South Korea
-
Hallym University Medical Center
Anyang-si, Gyeonggi-do, South Korea
-
Hanyang University Seoul Hospital
Seoul, South Korea
-
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
-
Koera University Guro Hospital
Seoul, South Korea
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea
-
Samsung Changwon Medical Center
Changwon, Gyeongsangnam-do, South Korea
-
Samsung Medical Center
Seoul, South Korea
-
Soon Chun Hyang University Hospital Cheonan
Cheonan, Chungcheongnam-do, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.